ADIPOQ and breast cancer: In 2019, Yoon et al. [57] found that AdipoQ levels were significantly associated with a decreased risk of breast cancer, colorectal cancer, and endometrial cancer, while leptin was associated with an increased risk of cancers such as endometrial cancer and kidney cancer.